Loading issuer details...
Pacific Edge Limited board of directors
7 current directors, average tenure 5.7 years.
| Director | Role | Independent | Appointed | Tenure | Committees |
|---|---|---|---|---|---|
| Simon Flood | Chair | Not recorded | 2025 | 0.9 yrs | — |
| Sarah Park | Independent Director | Yes | 2018 | 8.9 yrs | Investment Committee, Audit & Risk Committee |
| Peter Meintjes | Executive Director | No | 2025 | 1.0 yrs | Audit & Risk Committee (Chair), Remuneration Committee (Chair) |
| Anatole Masfen | Non-Independent Director | No | 2025 | 1.2 yrs | Audit & Risk Committee (Chair) |
| Antony (Tony) George Barclay | Independent Director | Yes | 2017 | 8.9 yrs | Audit & Risk Committee (Chair), Remuneration Committee, Investment Committee |
| Bryan Williams | Independent Director | Yes | 2013 | 13.4 yrs | Audit & Risk Committee (Chair), Remuneration Committee (Chair) |
| Anna Stove | Independent Director | Yes | 2021 | 5.7 yrs | Audit & Risk Committee (Chair), Remuneration Committee (Chair) |
PEB governance score breakdown
Pacific Edge Limited scores 88/100 (Excellent) on the NZXplorer Governance Risk Score for FY2026, based on 73% data coverage. See the GRS methodology.
- Board structure
- 22/25
- Shareholder rights
- 20/20
- Executive remuneration
- 6.5/10
Pacific Edge Limited largest shareholders
Top 10 registered holders of PEB as disclosed for FY2025. Registry holdings include custodians and nominees, which may hold on behalf of many underlying investors.
| # | Holder | Holding |
|---|---|---|
| 1 | New Zealand Central Securities Depository Limited | 34.50% |
| 2 | New Zealand Depository Nominee | 5.80% |
| 3 | FNZ Custodians Limited | 5.10% |
| 4 | Forsyth Barr Custodians Limited | 3.80% |
| 5 | Masfen Securities Limited | 3.70% |
| 6 | K One W One Limited | 2.60% |
| 7 | Custodial Services Limited | 1.70% |
| 8 | JBWERE (Nz) Nominees Limited | 1.00% |
| 9 | Leveraged Equities Finance Limited | 0.90% |
| 10 | Minggang Chen | 0.70% |
Recent PEB NZX announcements
The 10 most recent filings by Pacific Edge Limited to the NZX.
- SPH Notice - ANZ New Zealand Investments LimitedSubstantial Holder Notice
- Medicare Coverage for Triage & Triage Plus ConfirmedGeneral
- Interim Financial Result to be Announced 24 November 2026General
- SPH Notice - Harbour Asset Management LimitedSubstantial Holder Notice
- PACIFIC EDGE ADVANCES US COMMERCIAL RECOVERYOperational Update
- SPH Notice - FirstCape Group LimitedSubstantial Holder Notice
- Capital Change Notice - Exercise of OptionsCapital Change
- ASX 3H - Expiry of optionsGeneral
- ASX 2A - Exercise of OptionsGeneral
- Capital Change Notice - Options ExpiredCapital Change
Pacific Edge Limited (PEB) — frequently asked questions
What does Pacific Edge Limited do?
Pacific Edge is a cancer diagnostics company commercializing Cxbladder, a suite of non-invasive urine tests for bladder cancer detection. Pacific Edge Limited is listed on the NZX under the ticker PEB, in the Healthcare sector.
What is the Pacific Edge Limited (PEB) share price?
Pacific Edge Limited (NZX:PEB) shares closed at $0.27 on 11 November 2026, down 3.64% on the previous close. At that price its market capitalisation was about $271 million, based on 1,022,631,578 shares on issue as at 15 May 2026.
Who are the directors of Pacific Edge Limited?
Pacific Edge Limited has 7 current directors: Simon Flood (Chair), Sarah Park (Independent Director), Peter Meintjes (Executive Director), Anatole Masfen (Non-Independent Director), Antony (Tony) George Barclay (Independent Director), Bryan Williams (Independent Director) and Anna Stove (Independent Director). Average board tenure is 5.7 years.
Who is the chair of Pacific Edge Limited?
Simon Flood chairs the Pacific Edge Limited board, and has been a director since 2025.
Who is the CEO of Pacific Edge Limited?
Peter Meintjes is the CEO of Pacific Edge Limited.
Who are the largest shareholders of Pacific Edge Limited?
The largest registered holder of PEB shares in the FY2025 top-20 register was New Zealand Central Securities Depository Limited, with 34.50%, followed by New Zealand Depository Nominee (5.80%) and FNZ Custodians Limited (5.10%). Custodians and nominees on the register hold shares on behalf of other investors.
What is Pacific Edge Limited's governance score?
Pacific Edge Limited has an NZXplorer Governance Risk Score of 88/100 (Excellent) for FY2026, based on 73% data coverage.
When was the last Pacific Edge Limited annual meeting?
The most recent Pacific Edge Limited annual meeting on record was held on 20 August 2026.
Healthcare companies on the NZX
Compare Pacific Edge Limited with other NZX-listed healthcare companies.